(19)
(11) EP 4 262 810 A1

(12)

(43) Date of publication:
25.10.2023 Bulletin 2023/43

(21) Application number: 21835328.2

(22) Date of filing: 17.12.2021
(51) International Patent Classification (IPC): 
A61K 31/575(2006.01)
A61K 45/06(2006.01)
 A61K 31/495(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/575; A61K 31/495; A61K 45/06; A61P 35/00
 
C-Sets:
  1. A61K 31/575, A61K 2300/00;
  2. A61K 31/495, A61K 2300/00;
(86) International application number:
PCT/EP2021/086589
(87) International publication number:
WO 2022/129569 (23.06.2022 Gazette 2022/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 17.12.2020 EP 20306595

(71) Applicant: Université Bourgogne - Franche-Comté
25000 Besancon (FR)

(72) Inventors:
  • SASSI, Khouloud
    21000 DIJON (FR)
  • LIZARD, Gérard
    21121 FONTAINE LÈS DIJON (FR)

(74) Representative: Plasseraud IP 
66, rue de la Chaussée d'Antin
75440 Paris Cedex 09
75440 Paris Cedex 09 (FR)

   


(54) 5BETA, 6BETA-EPOXYCHOLESTEROL FOR USE IN THE TREATMENT OF CANCER